Clinical trial
Treatment Of Short Stature With Genotropin In Children Born Small For…
NCT00174421 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174421 |
|---|---|
| Title | Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height |
| Official title | Genotropin in Short Children Born Small for Gestational Ag - A Long-Term Study in Belgium |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Growth Disorder |
| Intervention type | Drug |
| Interventions | Treatment with Genotropin in different dosages |
| Enrollment | 36 |
| Start date | Apr 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 3, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: